Dupilumab therapy in Sézary syndrome misdiagnosed as atopic dermatitis: A case report
- 16 July 2020
- journal article
- letter
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (10), E356-E357
- https://doi.org/10.1111/1346-8138.15501
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patientsJournal of the American Academy of Dermatology, 2020
- Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trialsBritish Journal of Dermatology, 2019
- Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic DermatitisActa Dermato Venereologica, 2019
- Atopic Dermatitis-like Pre-Sézary Syndrome: Role of ImmunosuppressionActa Dermato-Venereologica, 2011
- Sézary syndrome in a young man with severe atopic dermatitisBritish Journal of Dermatology, 1999